STERIS plc (NYSE:STE) Shares Sold by Financiere des Professionnels Fonds d investissement inc.

Financiere des Professionnels Fonds d investissement inc. lessened its holdings in shares of STERIS plc (NYSE:STE) by 1.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 44,053 shares of the medical equipment provider’s stock after selling 783 shares during the period. Financiere des Professionnels Fonds d investissement inc.’s holdings in STERIS were worth $9,056,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in STE. Exchange Traded Concepts LLC acquired a new position in STERIS during the third quarter worth approximately $150,000. Creative Planning increased its position in STERIS by 1.4% during the third quarter. Creative Planning now owns 9,019 shares of the medical equipment provider’s stock worth $2,187,000 after buying an additional 126 shares during the period. Vontobel Holding Ltd. increased its position in STERIS by 8.9% during the third quarter. Vontobel Holding Ltd. now owns 2,011 shares of the medical equipment provider’s stock worth $488,000 after buying an additional 164 shares during the period. Bleakley Financial Group LLC increased its position in STERIS by 8.7% during the third quarter. Bleakley Financial Group LLC now owns 1,680 shares of the medical equipment provider’s stock worth $407,000 after buying an additional 134 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd increased its position in STERIS by 19.1% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 11,046 shares of the medical equipment provider’s stock worth $2,679,000 after buying an additional 1,774 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the company. Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. StockNews.com downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. Stephens reiterated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday, November 8th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

Insider Buying and Selling

In related news, SVP Cary L. Majors sold 1,682 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $217.32, for a total transaction of $365,532.24. Following the sale, the senior vice president now owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. The trade was a 12.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.14% of the stock is owned by insiders.

STERIS Trading Up 0.1 %

NYSE:STE opened at $219.54 on Monday. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.55 and a current ratio of 2.13. The stock has a fifty day moving average price of $212.95 and a two-hundred day moving average price of $223.99. The stock has a market capitalization of $21.67 billion, a price-to-earnings ratio of 46.61 and a beta of 0.84.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.